Dr. J

Chairman of Protext Mobility Inc.

Present Positions

• Chairman/President of Protext Mobility Inc. protxtm.com
• Chairman/President & Co-Founder of RSAMMD Acquisitions LLC rsammda.com
• Chairman/President of the Republic of South Africa Medical Marijuana Dispensaries (RSAMMD) rsammd.co.za
• Chairman of National Commodity Board for Cannabis & Indigenous Flora
• C/O Leeds Boerdery

Executive Profile

Dr. Ahmed Jamaloodeen is a South African medical doctor, farmer, agricultural innovator, global cannabis industry leader, and biotechnology executive recognized for operating at the intersection of medicine, sustainable agriculture, plant science, biotechnology, and global cannabis infrastructure development.

As Chairman and President of Protext Mobility Inc., Dr. Jamaloodeen plays a central leadership role in advancing the company’s vertically integrated strategy spanning large-scale cultivation, advanced extraction technology, plant-based pharmaceutical development, real-world asset (RWA) infrastructure, and global commercialization.

Widely respected for his multidisciplinary expertise and systems-level thinking, Dr. Jamaloodeen has become one of the leading figures helping position South Africa as an emerging global hub for medicinal cannabis, industrial hemp, agricultural innovation, and sustainable bioeconomic development.

As a registered medical practitioner with the Health Professions Council of South Africa (HPCSA), he combines clinical knowledge with practical agricultural implementation, large-scale farming operations, industry development, and scientific research — creating a uniquely integrated approach to healthcare, cultivation, education, and economic enablement.

Strategic Role in the Protext Mobility Merger

Dr. Jamaloodeen played a critical role in the strategic evolution, acquisition, and expansion of Protext Mobility Inc. through the merger with RSAMMD Acquisitions LLC.

Working alongside Mr. Dylon Du Plooy, he helped establish the operational and agricultural foundation upon which the company’s vertically integrated biotechnology platform was built.

Through Leeds Boerdery and RSAMMD affiliated operations, Dr. Jamaloodeen provided direct access to:

• Licensed Farms
• Government-Issued Cultivation Permits
• Agricultural Infrastructure
• Research Environments
• Cultivation Logistics
• Long-Term Farming Infrastructure

He also made substantial contributions toward:

• Seed Inventory Development
• Genetic Preservation
• Cultivation Programs
• Production Scalability
• Global Commercialization Preparation

Large-Scale Farming & Sustainable Agriculture

Operating from Newcastle, KwaZulu-Natal, Dr. Jamaloodeen oversees approximately 5,000 hectares of permitted agricultural land dedicated to hemp farming, eco-farming, and organic cultivation systems.

His agricultural operations incorporate:

• No-Till Farming
• Crop Rotation
• Regenerative Agriculture
• Ecological Soil Management
• AI-Assisted Agricultural Systems
• Zero-Waste Farming Principles

Under his leadership, the farming platform has evolved into a multi-disciplinary agricultural ecosystem focused not only on cultivation, but also on education, community development, food security, and long-term environmental sustainability.

Initiatives integrated into the operations include:

• Farm Schools
• Community Feeding Schemes
• Farmer Enablement Programs
• Employment Creation
• Agricultural Skills Development
• Sustainable Rural Economic Participation

Dr. Jamaloodeen views industrial hemp and cannabis as transformational industries capable of driving poverty eradication, agricultural modernization, and economic inclusion throughout South Africa and the broader African continent.

His work reflects a deep commitment to ensuring that large-scale agricultural development benefits both industry and local communities simultaneously.

Advanced Plant Science & Research

Dr. Jamaloodeen’s expertise extends deeply into:

• Agro-Processing
• Industrial Hemp Development
• Seed Technology
• Cloning & Genetic Preservation
• Tissue Culture
• Cannabinoid Extraction Systems
• Botanical Processing
• Sustainable Cultivation Science

As an official hemp permit researcher, he works alongside government centres of higher education, research institutions, and industry partners to advance scientific understanding and practical implementation within regulated cannabis and hemp frameworks.

His multidisciplinary understanding of both agricultural science and medical application has helped bridge the gap between cultivation infrastructure and clinical research — a critical requirement in the development of pharmaceutical-grade cannabinoid products.

Clinical Research, SAHPRA Ethics & Cannabinoid Pain Studies

Dr. Jamaloodeen has also played a significant role in the advancement of clinical cannabinoid research focused on the investigation of cannabinoid-based therapeutics as a potential alternative or adjunct to opioid-based treatments in chronic pain management.

As a registered medical practitioner and designated medical doctor of record associated with the study framework, he has been directly involved in helping oversee the:

• Medical Governance
• Clinical Oversight
• Patient Safety Frameworks
• Ethics Compliance Protocols
• SAHPRA-Aligned Regulatory Structures
• Cannabinoid Therapeutic Evaluation

Dr. Jamaloodeen also serves as one of the holders of the pharmaceutical ethics certification associated with the study framework — a regulatory requirement necessary for the advancement of ethics-approved cannabinoid clinical research initiatives under South African regulatory standards.

The research initiatives focus on evaluating the role of:

• Cannabinoids
• Advanced Cannabinoid Formulations
• Non-Opioid Therapeutic Strategies
• Chronic Pain Management Approaches
• Patient Quality of Life Improvement
• Reduction of Opioid Dependency Risk

His involvement reflects a broader commitment toward:

• Scientifically Validated Medicinal Cannabis Research
• Responsible Clinical Implementation
• Regulatory-Compliant Pharmaceutical Development
• Patient-Centered Healthcare Innovation

Live Plant Extraction & Scientific Validation

One of Dr. Jamaloodeen’s most significant contributions to Protext Mobility involved the advancement and operational implementation of the company’s live plant extraction initiatives.

Through the collaboration between The Republic of South Africa Medical Marijuana Dispensaries (RSAMMD) and Protext Mobility, Dr. Jamaloodeen helped facilitate the successful testing and validation of proprietary live cannabis plant extraction technology in South Africa.

These initiatives involved the processing of freshly harvested cannabis and hemp plants using proprietary sonoluminescence extraction methodologies designed to preserve the plant’s full phytonutrient profile while enhancing bioavailability.

Working alongside Mr. Du Plooy, Roger Duffield, Dr. Hurley and the broader technical team, Dr. Jamaloodeen helped provide:

• Licensed Cultivation Environments
• Live Plant Material
• Regulated Testing Infrastructure
• Agricultural and Scientific Support Systems
• Advanced Processing Capabilities
• Specialized Extraction Equipment Access

Independent third-party laboratory analysis validated that the extraction process could:

• Preserve Cannabinoid Precursor Acids such as THC-A and CBDA
• Retain Full-Spectrum Phytonutrients (“Entourage Effect”)
• Produce Non-Psychoactive Cannabinoid Emulsions
• Achieve Significantly Enhanced Bioavailability
• Reduce Required Dosage Levels
• Support Future Pharmaceutical Development Pathways

These developments represented an important milestone in plant-based pharmaceutical research and positioned the company at the convergence of biotechnology, natural medicine, advanced extraction science, and global commercialization.

Industry collaborators recognized Dr. Jamaloodeen’s unique capability to bridge:

• Large-Scale Cultivation
• Medical Knowledge
• Scientific Implementation
• Extraction Infrastructure
• Operational Execution

A notable acknowledgment came from an extraction technology developer who specifically referenced Dr. Jamaloodeen’s capability and infrastructure support in continuing advanced cannabinoid experimentation and research development.

Global Cannabis Industry Leadership

Dr. Jamaloodeen has become a prominent advocate for mass collaboration, industry unity, and global cannabis development.

He believes cannabis and hemp represent transformational industries capable of integrating:

• Agriculture
• Medicine
• Education
• Tourism
• Indigenous Knowledge Systems
• Scientific Research
• International Investment
• Sustainable Development

into a unified economic ecosystem.

He currently serves as:

• National Treasurer of the Cannabis Development Council of South Africa (CDCSA)
• Vice-Treasurer of CDCKZN
• Chairman of the National Cannabis Commodity Board (NEC)

where he contributes toward:

• Industry Development
• Policy Advancement
• Farmer Enablement
• Education Initiatives
• Responsible Regulatory Frameworks
• International Industry Collaboration

Working in collaboration with the African Farmers Association of South Africa (AFASA), Dr. Jamaloodeen has participated in numerous cannabis education and enablement workshops throughout South Africa, helping emerging farmers and communities understand the medicinal, agricultural, and industrial opportunities associated with cannabis and hemp cultivation.

Indigenous Knowledge Systems & Cultural Advocacy

Dr. Jamaloodeen is also actively involved in indigenous knowledge systems (IKS), serving as:

• Branch Head (KZN) for the Koisan Structure
• Member of the Griqua National Council

His work advocates for the preservation and integration of traditional medicinal knowledge and indigenous agricultural practices within modern scientific, educational, and commercial systems.

He believes that sustainable progress requires balancing advanced technology with traditional wisdom and community-based knowledge systems.

RWA Tokenization & Next-Generation Infrastructure

As Protext Mobility evolved beyond traditional biotechnology and cultivation operations, Dr. Jamaloodeen became increasingly involved in the company’s expansion into real-world asset (RWA) tokenization and digital financial infrastructure.

His contribution focuses on helping connect:

• Physical Agricultural Outputs
• Biological Assets
• Land-Based Production Systems
• Cultivation Infrastructure

with next-generation digital financial ecosystems designed to improve transparency, scalability, liquidity, and global accessibility.

This strategic direction seeks to bridge agriculture, biotechnology, and digital asset frameworks into integrated systems capable of supporting long-term industrial growth and cross-border capital participation.

Qualifications

• Dr. Ahmed Jamaloodeen is a registered HPCSA medical doctor in South Africa. https://www.hpcsa.co.za/
• Extraordinary Envoy to the Grand Traditional Chiefs of Koisan, who has the mission to develop fraternal relations of cooperation, economics, social systems, and culture with all people without distinction of race, colour, or religion, for the peace and prosperity of mankind, and for the glory and love of Almighty God, our Creator.

Qualifications

• Dr Ahmed Jamaloodeen is a registered HPCSA Medical Doctor in South Africa. https://www.hpcsa.co.za/
• Grand Archon Financial and Economic Chief.
• Extraordinary Envoy to the Grand Traditional Chiefs of Koisan, who has the mission to Develop our Fraternal Relations of Cooperation, Economic, Socials, Cultures with all the People Without Distinction of Race and Colour or Religion, For the Peace and Prosperity of Man Kind, For the Glory and Love of The Almighty God our Creator.